発表論文 - 2011年
- Watanabe A, Kiyota N, Yamasaki T, Tanda K, Miyagoe T, Sakamoto M, and Otsuka M.
Design and stereoselective synthesis of four peptide nucleic acid monomers with cyclic structures in backbone.
Journal of Heterocyclic Chemistry 48: 1132-1139, 2011. - Fujita MJ, Kimura N, Sakai A, Ichikawa Y, Hanyu T, and Otsuka M.
Cloning of the biosynthetic gene cluster and heterologous production of Vibrioferrin from a marine metagenomic library.
Bioscience, Biotechnology, and Biochemistry 75: 2283-2287, 2011. - Anraku K, Inoue T, Sugimoto K, Kudo K, Okamoto Y, Morii T, Mori Y, and Otsuka M.
Design and synthesis of biotinylated inositol 1,3,4,5-tetrakisphosphate targeting Grp1 pleckstrin homology domain.
Bioorganic & Medicinal Chemistry 19: 6833-6841, 2011. - Kanemaru Y, Momiki Y, Matsuura S, Horikawa T, Gohda J, Inoue J, Okamoto Y, Fujita M, and Otsuka M.
An artificial copper complex incorporating a cell-penetrating peptide inhibits NF-κB activation.
Chemical & Pharmaceutical Bulletin 59: 1555-1558, 2011. - Yamakawa N, Suemasu S, Matoyama M, Tanaka K, Katsu T, Miyata K, Okamoto Y, Otsuka M, and Mizushima T.
Synthesis and biological evaluation of loxoprofen derivatives.
Bioorganic & Medicinal Chemistry 19: 3299-3311, 2011. - Ejima T, Hirota M, Mizukami T, Otsuka M, and Fujita M.
An anti-HIV-1 compound that increases steady-state expression of apoplipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G.
International Journal of Molecular Medicine 28: 613-616, 2011. - Fujii H, Ato M, Takahashi Y, Otake K, Hashimoto S, Kaji T, Tsunetsugu-Yokota Y, Fujita M, Adachi A, Nakayama T, Taniguchi M, Koyasu S, and Takemori T.
HIV-1 Nef impairs multiple T-cell functions in antigen-specific immune response in mice .
International Immunology 23: 433-441, 2011. - Nomaguchi M, Fujita M, and Adachi A.
The fourth major restriction factor against HIV/SIV.
Frontiers in Microbiology 2: 132, 2011. - Ashizawa T, Miyata H, Ishii H, Oshita C, Matsuno K, Masuda Y, Furuya T, Okawara T, Otsuka M, Ogo N, Asai A, and Akiyama Y.
Antitumor activity of a novel small molecule STAT3 inhibitor against a human lymphoma cell line with high STAT3 activation.
International Journal of Oncology 38: 1245-1252, 2011.